tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Liver Cirrhosis, Alcoholic D008104 17 associated lipids
Liver Cirrhosis, Biliary D008105 12 associated lipids
Liver Diseases D008107 31 associated lipids
Long QT Syndrome D008133 10 associated lipids
Lung Abscess D008169 1 associated lipids
Lung Diseases D008171 37 associated lipids
Lung Neoplasms D008175 171 associated lipids
Lupus Erythematosus, Cutaneous D008178 2 associated lipids
Lupus Erythematosus, Discoid D008179 1 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lupus Nephritis D008181 8 associated lipids
Lymphocele D008210 1 associated lipids
Lymphocytic Choriomeningitis D008216 1 associated lipids
Lymphoma D008223 18 associated lipids
Lymphomatoid Granulomatosis D008230 2 associated lipids
Lymphoproliferative Disorders D008232 7 associated lipids
Malacoplakia D008287 1 associated lipids
Malocclusion, Angle Class II D008312 1 associated lipids
Mastocytosis D008415 5 associated lipids
Mediastinal Diseases D008477 1 associated lipids
Mediastinal Emphysema D008478 1 associated lipids
Mediastinitis D008480 2 associated lipids
Megacolon, Toxic D008532 1 associated lipids
Melanoma D008545 69 associated lipids
Memory Disorders D008569 33 associated lipids
Meningococcal Infections D008589 3 associated lipids
Meningoencephalitis D008590 4 associated lipids
Metaplasia D008679 7 associated lipids
Mite Infestations D008924 1 associated lipids
Molluscum Contagiosum D008976 2 associated lipids
Mouth Diseases D009059 5 associated lipids
Moyamoya Disease D009072 1 associated lipids
Multiple Myeloma D009101 13 associated lipids
Muscular Dystrophies D009136 10 associated lipids
Mutism D009155 1 associated lipids
Myasthenia Gravis D009157 5 associated lipids
Mycobacterium Infections D009164 7 associated lipids
Mycobacterium Infections, Nontuberculous D009165 8 associated lipids
Mycoses D009181 18 associated lipids
Myelitis D009187 1 associated lipids
Myxedema D009230 2 associated lipids
Nail Diseases D009260 2 associated lipids
Necrobiosis Lipoidica D009335 2 associated lipids
Neoplasm Invasiveness D009361 23 associated lipids
Neoplasm Recurrence, Local D009364 5 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Nephritis D009393 19 associated lipids
Nephritis, Hereditary D009394 1 associated lipids
Nephritis, Interstitial D009395 10 associated lipids
Nephrotic Syndrome D009404 11 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
Cho JH et al. Development of novel fast-dissolving tacrolimus solid dispersion-loaded prolonged release tablet. 2014 Eur J Pharm Sci pmid:24388864
Smoter P et al. Risk factors of acute renal failure after orthotopic liver transplantation: single-center experience. 2014 Transplant. Proc. pmid:25380918
Frassetto LA et al. Best single time point correlations with AUC for cyclosporine and tacrolimus in HIV-infected kidney and liver transplant recipients. 2014 Transplantation pmid:24389906
Lerut JP et al. Is minimal, [almost] steroid-free immunosuppression a safe approach in adult liver transplantation? Long-term outcome of a prospective, double blind, placebo-controlled, randomized, investigator-driven study. 2014 Ann. Surg. pmid:25379858
Hitzler JK et al. Outcome of transplantation for acute lymphoblastic leukemia in children with Down syndrome. 2014 Pediatr Blood Cancer pmid:24391118
Wu Y et al. Increased macrophage activation inhibited by tacrolimus in the kidney of diabetic rats. 2014 Nephron Exp. Nephrol. pmid:25376933
Levitsky J and Feng S Sirolimus and mTOR inhibitors in liver transplantation: the wheel has come full circle. 2014 Am. J. Transplant. pmid:24620373
Muhetaer G et al. Clinical significance of peripheral blood lymphocyte sensitivity to glucocorticoids for the differentiation of high-risk patients with decreased allograft function after glucocorticoid withdrawal in renal transplantation. 2014 Clin Ther pmid:25037282
Backes AN et al. Effects of tacrolimus and insulin in a liver regeneration model in growing animals with portal vein stenosis: immunohistochemical and molecular studies. 2014 Pediatr. Surg. Int. pmid:24468714
Tavira B et al. [Pharmacogenetics of tacrolimus: from bench to bedside?]. 2014 Nefrologia pmid:24463861
Qin XL et al. Effect of Tacrolimus on the pharmacokinetics of bioactive lignans of Wuzhi tablet (Schisandra sphenanthera extract) and the potential roles of CYP3A and P-gp. 2014 Phytomedicine pmid:24462213
Zheng X et al. Patient with neuromyelitis optica spectrum disorder combined with Sjögren's syndrome relapse free following tacrolimus treatment. 2014 Intern. Med. pmid:25318807
Asrani SK et al. De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial. 2014 Am. J. Transplant. pmid:24456026
Nevers W et al. Safety of tacrolimus in pregnancy. 2014 Can Fam Physician pmid:25316742
Oellerich M et al. Use of graft-derived cell-free DNA as an organ integrity biomarker to reexamine effective tacrolimus trough concentrations after liver transplantation. 2014 Ther Drug Monit pmid:24452066
Wang J et al. Molecular mechanisms of FK506-induced hypertension in solid organ transplantation patients. 2014 Chin. Med. J. pmid:25316243
Sagiroglu T et al. Protective effect of everolimus on renal ischemia reperfusion injury in rats. 2014 Saudi J Kidney Dis Transpl pmid:24625994
Khorrami A et al. Tacrolimus ameliorates functional disturbances and oxidative stress in isoproterenol-induced myocardial infarction. 2014 Daru pmid:25312839
Shimizu M et al. Successful multitarget therapy using mizoribine and tacrolimus for refractory Takayasu arteritis. 2014 Rheumatology (Oxford) pmid:24609060
Golubović B et al. Total plasma protein effect on tacrolimus elimination in kidney transplant patients--population pharmacokinetic approach. 2014 Eur J Pharm Sci pmid:24184751
Hu YM et al. Casein kinase II inhibition reverses pain hypersensitivity and potentiated spinal N-methyl-D-aspartate receptor activity caused by calcineurin inhibitor. 2014 J. Pharmacol. Exp. Ther. pmid:24610957
Bäckman L and Persson CA An observational study evaluating tacrolimus dose, exposure, and medication adherence after conversion from twice- to once-daily tacrolimus in liver and kidney transplant recipients. 2014 Ann. Transplant. pmid:24637379
Mai HL et al. IL-7 receptor blockade following T cell depletion promotes long-term allograft survival. 2014 J. Clin. Invest. pmid:24569454
Ramachandran R et al. Tacrolimus therapy in adult-onset steroid-resistant nephrotic syndrome due to a focal segmental glomerulosclerosis single-center experience. 2014 Nephrol. Dial. Transplant. pmid:24771498
Tokuoka H et al. Nurr1 expression is regulated by voltage-dependent calcium channels and calcineurin in cultured hippocampal neurons. 2014 Neurosci. Lett. pmid:24291696
Capone F et al. Synergistic antitumor effect of Doxorubicin and tacrolimus (FK506) on hepatocellular carcinoma cell lines. 2014 ScientificWorldJournal pmid:24701168
Boran M et al. Determining renal resistive and pulsatility indexes long-term after kidney transplantation in kidney transplant recipients on cyclosporine a-, tacrolimus-, or sirolimus-based regimens. 2014 Transplant. Proc. pmid:24935296
Fuchs U et al. Clinical outcome in heart transplant recipients receiving everolimus in combination with dosage reduction of the calcineurin inhibitor cyclosporine A or tacrolimus. 2014 Transpl. Immunol. pmid:24932812
Motomura H et al. Inhibitory effect of tacrolimus on progression of joint damage in patients with rheumatoid arthritis. 2014 Int J Rheum Dis pmid:24251619
Han N et al. Population pharmacokinetic-pharmacogenetic model of tacrolimus in the early period after kidney transplantation. 2014 Basic Clin. Pharmacol. Toxicol. pmid:24238261
Yasukochi Y et al. Reduction of serum TARC levels in atopic dermatitis by topical anti-inflammatory treatments. 2014 Asian Pac. J. Allergy Immunol. pmid:25268342
Zhang L et al. Ambrisentan improves the outcome of rats with liver transplantation partially through reducing nephrotoxicity. 2014 Eur Rev Med Pharmacol Sci pmid:25268107
Donnadieu B et al. Central retinal vein occlusion-associated tacrolimus after liver transplantation. 2014 Transplantation pmid:25955343
Rangel EB Tacrolimus in pancreas transplant: a focus on toxicity, diabetogenic effect and drug-drug interactions. 2014 Expert Opin Drug Metab Toxicol pmid:25255841
Sharp WW et al. Dynamin-related protein 1 (Drp1)-mediated diastolic dysfunction in myocardial ischemia-reperfusion injury: therapeutic benefits of Drp1 inhibition to reduce mitochondrial fission. 2014 FASEB J. pmid:24076965
Wasilewski G et al. Inadequate blood pressure control in orthotopic heart transplant: is there a role of kidney function and immunosuppressive regimen? 2014 Transplant. Proc. pmid:25380929
Al-Harbi NO et al. Protection against tacrolimus-induced cardiotoxicity in rats by olmesartan and aliskiren. 2014 Toxicol. Mech. Methods pmid:25199528
Wilusz M et al. Effect of immunosuppressive therapy on the serum fatty acids of phospholipids fraction in patients after heart transplantation. 2014 Transplant. Proc. pmid:25380928
Notaro E et al. Dose conversion factor between cyclosporine and tacrolimus in pediatric heart transplant recipients. 2014 J. Heart Lung Transplant. pmid:24854566
Lan CC et al. Tacrolimus abrogates TGF-β1-induced type I collagen production in normal human fibroblasts through suppressing p38MAPK signalling pathway: implications on treatment of chronic atopic dermatitis lesions. 2014 J Eur Acad Dermatol Venereol pmid:23301526
Noceti OM et al. Tacrolimus pharmacodynamics and pharmacogenetics along the calcineurin pathway in human lymphocytes. 2014 Clin. Chem. pmid:25142246
Guy-Viterbo V et al. Influence of donor-recipient CYP3A4/5 genotypes, age and fluconazole on tacrolimus pharmacokinetics in pediatric liver transplantation: a population approach. 2014 Pharmacogenomics pmid:25141896
Cavalli RC et al. Analysis of the histology of the scar bladder and biochemical parameters of rats with a solitary kidney undergoing immunosuppression with tacrolimus. 2014 Acta Cir Bras pmid:25140592
Zhao WY et al. Single kidneys transplanted from small pediatric donors less than 15 kilograms into pediatric recipients. 2014 Transplantation pmid:25955345
Mabe S et al. Detecting protein-protein interactions based on kinase-mediated growth induction of mammalian cells. 2014 Sci Rep pmid:25135216
Sol Fustiñana M et al. Protein degradation by ubiquitin-proteasome system in formation and labilization of contextual conditioning memory. 2014 Learn. Mem. pmid:25135196
Elens L et al. Impact of POR*28 on the pharmacokinetics of tacrolimus and cyclosporine A in renal transplant patients. 2014 Ther Drug Monit pmid:24061445
Imataki O et al. Reversible cerebral vasoconstriction syndrome resulted in cerebral infarction after allogeneic stem cell transplantation: a case report. 2014 Ann. Hematol. pmid:24061786
Hagihara Y et al. Infliximab and/or immunomodulators inhibit immune responses to trivalent influenza vaccination in adults with inflammatory bowel disease. 2014 J Crohns Colitis pmid:24011513
Kilinc S et al. The effects of preoperative immunosuppressive therapy on ischemia and reperfusion (I/R) injury in healthy rats. 2014 Int Urol Nephrol pmid:24014133
Gürkan A et al. Alpha 2 integrin gene (ITGA2) polymorphism in renal transplant recipients with and without drug induced gingival overgrowth. 2014 Arch. Oral Biol. pmid:24581850
Freire-Cobo C et al. The calcineurin inhibitor Ascomicin interferes with the early stage of the epileptogenic process induced by Latrunculin A microperfusion in rat hippocampus. 2014 J Neuroimmune Pharmacol pmid:25104570
Shen T et al. A modified protocol with rituximab and intravenous immunoglobulin in emergent ABO-incompatible liver transplantation for acute liver failure. 2014 HBPD INT pmid:25100124
Wang B et al. Multifaceted interaction of the traditional Chinese medicinal herb Schisandra chinensis with cytochrome P450-mediated drug metabolism in rats. 2014 J Ethnopharmacol pmid:25091466
Verghese PS et al. Calcineurin inhibitors in HLA-identical living related donor kidney transplantation. 2014 Nephrol. Dial. Transplant. pmid:24414376
Da-Long S et al. Tacrolimus on Kimura's disease: a case report. 2014 Oral Surg Oral Med Oral Pathol Oral Radiol pmid:22939325
Kyriakou A et al. Therapeutic efficacy of topical calcineurin inhibitors in plasma cell balanitis: case series and review of the literature. 2014 Dermatology (Basel) pmid:24434685
Viecelli A et al. Diagnostic and management dilemma of a pancreas-kidney transplant recipient with aplastic anaemia. 2014 BMJ Case Rep pmid:25257886
Ikeuchi H et al. Efficacy and safety of multi-target therapy using a combination of tacrolimus, mycophenolate mofetil and a steroid in patients with active lupus nephritis. 2014 Mod Rheumatol pmid:24252014
Jaksch P et al. Alemtuzumab in lung transplantation: an open-label, randomized, prospective single center study. 2014 Am. J. Transplant. pmid:25039364
Segarra-Medrano A et al. Evolution of antibody titre against the M-type phospholipase A2 receptor and clinical response in idiopathic membranous nephropathy patients treated with tacrolimus. 2014 Nefrologia pmid:25036063
Bax K et al. Rapid resolution of tacrolimus intoxication-induced AKI with a corticosteroid and phenytoin. 2014 Ann Pharmacother pmid:25104567
Dessilly G et al. ABCB1 1199G>A genetic polymorphism (Rs2229109) influences the intracellular accumulation of tacrolimus in HEK293 and K562 recombinant cell lines. 2014 PLoS ONE pmid:24621983
Falconer SJ et al. Conversion from twice-daily to once-daily tacrolimus in simultaneous pancreas-kidney transplant patients. 2014 Transplant. Proc. pmid:24935313
Hacker C et al. Falsely elevated cyclosporin and tacrolimus concentrations over prolonged periods of time due to reversible adsorption to central venous catheters. 2014 Clin. Chim. Acta pmid:24631133
Terada Y et al. Intestinal P-glycoprotein expression is multimodally regulated by intestinal ischemia-reperfusion. 2014 J Pharm Pharm Sci pmid:24934555
Singla AK et al. Cerulomycin Caerulomycin [corrected] A: a potent novel immunosuppressive agent. 2014 Transplantation pmid:24949498
Goring SM et al. A network meta-analysis of the efficacy of belatacept, cyclosporine and tacrolimus for immunosuppression therapy in adult renal transplant recipients. 2014 Curr Med Res Opin pmid:24628478
Mai S et al. In vitro and in vivo release characteristics of Tacrolimus (FK506) from an episcleral drug-delivery implant. 2014 J Ocul Pharmacol Ther pmid:24933028
Urbanowicz T et al. Comparison of conventional tacrolimus versus prolong release formula as initial therapy in heart transplantation. 2014 Ann. Transplant. pmid:24949728
Nomura H et al. A patient with lupus miliaris disseminatus faciei treated successfully with a combination of oral metronidazole and topical tacrolimus. 2014 J. Dermatol. pmid:24931738
Fuchs U et al. Incidence of malignant neoplasia after heart transplantation--a comparison between cyclosporine a and tacrolimus. 2014 Ann. Transplant. pmid:24953848
Elamin S et al. Co-administration of ketoconazole and tacrolimus to kidney transplant recipients: cost minimization and potential metabolic benefits. 2014 Saudi J Kidney Dis Transpl pmid:24969193
Gibbs BF et al. Highly specific targeting of human leukocytes using gold nanoparticle-based biologically active conjugates. 2014 J Biomed Nanotechnol pmid:24804546
Richards KR et al. Tacrolimus trough level at discharge predicts acute rejection in moderately sensitized renal transplant recipients. 2014 Transplantation pmid:24784360
Hallowell RW and Danoff SK Interstitial lung disease associated with the idiopathic inflammatory myopathies and the antisynthetase syndrome: recent advances. 2014 Curr Opin Rheumatol pmid:25203119
Liu Z et al. Tacrolimus-based versus cyclosporine-based immunosuppression in hepatitis C virus-infected patients after liver transplantation: a meta-analysis and systematic review. 2014 PLoS ONE pmid:25198195
Katayama M et al. Preliminary study of interaction of clarithromycin with tacrolimus in cats. 2014 J. Vet. Med. Sci. pmid:25099737
Ricardo E et al. In vivo and in vitro acquisition of resistance to voriconazole by Candida krusei. 2014 Antimicrob. Agents Chemother. pmid:24867987
Shihab F et al. Focus on mTOR inhibitors and tacrolimus in renal transplantation: pharmacokinetics, exposure-response relationships, and clinical outcomes. 2014 Transpl. Immunol. pmid:24861504
Almeida-Paulo GN et al. Limited sampling strategies for tacrolimus exposure (AUC0-24) prediction after Prograf(®) and Advagraf(®) administration in children and adolescents with liver or kidney transplants. 2014 Transpl. Int. pmid:24861353
Chamienia A et al. Open prospective study to evaluate cardiovascular risk factors and renal function in 2 dosage regimens of tacrolimus combined with mycophenolate mofetil and steroids in renal transplant patients: 5-year results. 2014 Transplant. Proc. pmid:25380901
Doren EL and Aya-ay ML Pyoderma gangrenosum following breast reduction: treatment with topical tacrolimus and steroids. 2014 Aesthet Surg J pmid:24448967
Lee CM et al. Monotherapy with tacrolimus for heart and liver transplant: a case report. 2014 Transplant. Proc. pmid:24767396
Lin YH and Pratt MR A dual small-molecule rheostat for precise control of protein concentration in Mammalian cells. 2014 Chembiochem pmid:24615791
Abe T et al. Risk factors for development of new-onset diabetes mellitus and progressive impairment of glucose metabolism after living-donor liver transplantation. 2014 Transplant. Proc. pmid:24767367
Mita A et al. Optimal initial dose of orally administered once-daily extended-release tacrolimus following intravenous tacrolimus therapy after liver transplantation. 2014 Transplant. Proc. pmid:24767351
Jin L et al. Dipeptidyl peptidase IV inhibitor MK-0626 attenuates pancreatic islet injury in tacrolimus-induced diabetic rats. 2014 PLoS ONE pmid:24959755
Wan XC and Dimov V Pharmacokinetic evaluation of topical calcineurin inhibitors for treatment of allergic conjunctivitis. 2014 Expert Opin Drug Metab Toxicol pmid:24490943
Zhang X et al. Profiling of drug binding proteins by monolithic affinity chromatography in combination with liquid chromatography-tandem mass spectrometry. 2014 J Chromatogr A pmid:25064533
Philipone E et al. Oral ulcerations as a sequela of tacrolimus and mycophenolate mofetil therapy. 2014 Oral Surg Oral Med Oral Pathol Oral Radiol pmid:25457894
Chen C et al. Rapid construction of a Bacterial Artificial Chromosomal (BAC) expression vector using designer DNA fragments. 2014 Plasmid pmid:25454071
Olson KA et al. Toxic tacrolimus levels after application of topical tacrolimus and use of occlusive dressings in two bone marrow transplant recipients with cutaneous graft-versus-host disease. 2014 Pharmacotherapy pmid:24700567
Momohara S et al. Recent trends in orthopedic surgery aiming to improve quality of life for those with rheumatoid arthritis: data from a large observational cohort. 2014 J. Rheumatol. pmid:24692532
Lin Q et al. Pharmacological mobilization of endogenous stem cells significantly promotes skin regeneration after full-thickness excision: the synergistic activity of AMD3100 and tacrolimus. 2014 J. Invest. Dermatol. pmid:24682043
Díaz-García C et al. Pregnancy after allogeneic uterus transplantation in the rat: perinatal outcome and growth trajectory. 2014 Fertil. Steril. pmid:25439799
Tsunashima D et al. Assessment of tacrolimus absorption from the human intestinal tract: open-label, randomized, 4-way crossover study. 2014 Clin Ther pmid:24680768
Ibrahim O et al. The role of infliximab in the treatment of superficial granulomatous pyoderma of the head and neck. 2014 J. Am. Acad. Dermatol. pmid:25438004
Kraaij MD et al. Human monocytes produce interferon-gamma upon stimulation with LPS. 2014 Cytokine pmid:24680476
Lee CH et al. Raised tacrolimus level and acute renal injury associated with acute gastroenteritis in a child receiving local rectal tacrolimus. 2014 Clin J Gastroenterol pmid:26183743